Atria Investments Inc Has $283,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Atria Investments Inc lessened its position in Phibro Animal Health Co. (NASDAQ:PAHC) by 67.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,578 shares of the company’s stock after selling 25,588 shares during the period. Atria Investments Inc’s holdings in Phibro Animal Health were worth $283,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of PAHC. CWM LLC increased its position in shares of Phibro Animal Health by 89.8% in the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after buying an additional 1,035 shares in the last quarter. nVerses Capital LLC bought a new stake in shares of Phibro Animal Health in the third quarter worth about $70,000. Summit Securities Group LLC acquired a new stake in shares of Phibro Animal Health during the second quarter worth about $83,000. China Universal Asset Management Co. Ltd. lifted its holdings in shares of Phibro Animal Health by 63.7% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after purchasing an additional 1,522 shares in the last quarter. Finally, Algert Global LLC acquired a new position in shares of Phibro Animal Health in the 2nd quarter valued at approximately $193,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Price Performance

NASDAQ PAHC opened at $23.74 on Friday. Phibro Animal Health Co. has a 12-month low of $9.49 and a 12-month high of $25.98. The firm’s 50 day moving average is $23.13 and its 200-day moving average is $19.94. The company has a market capitalization of $961.54 million, a PE ratio of 55.21, a price-to-earnings-growth ratio of 0.62 and a beta of 0.51. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.34 by $0.07. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. The firm had revenue of $273.16 million for the quarter, compared to analysts’ expectations of $262.44 million. Equities research analysts anticipate that Phibro Animal Health Co. will post 1.59 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th will be given a dividend of $0.12 per share. The ex-dividend date is Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 2.02%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 111.63%.

Analyst Ratings Changes

Several analysts have commented on PAHC shares. JPMorgan Chase & Co. started coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price on the stock. StockNews.com lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday. Barclays upped their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th. Finally, Bank of America lifted their price target on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, August 30th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $16.50.

Insider Buying and Selling at Phibro Animal Health

In other news, Director E Thomas Corcoran purchased 5,000 shares of the business’s stock in a transaction on Wednesday, September 4th. The stock was purchased at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the purchase, the director now directly owns 25,000 shares in the company, valued at $500,500. The trade was a 25.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 50.07% of the company’s stock.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.